Anxiety News and Research

Latest Anxiety News and Research

Mental distress increases risk of heart disease in diabetics

“Mental health professionals need to be involved in the care of diabetic persons,” says study author Tara W. Strine, M.P.H., an epidemiologist in the Division of Adult and Community Health at the Centers for Disease Control and Prevention. The findings appear in the American Journal of Health Behavior.

30 Aug 2004

New study confirms benefits of rimonabant in weight loss

Phase III clinical study comparing placebo to rimonabant, the first agent in a new therapeutic class known as selective cannabinoid type 1 (CB1) blockers, showed that overweight or obese people taking rimonabant 20mg once daily benefited from a significant reduction in their body weight

29 Aug 2004

U.S. FDA study shows Canadian drugs to be more expensive

If you think all drugs from Canada are cheaper than U.S. drugs, think again. In the United States, generic drugs - roughly half of all prescriptions - are often cheaper than both Canadian brand-name drugs and Canadian generic drugs, according to a study by the Food and Drug Administration.

29 Aug 2004

First study of the emotional turmoil caregivers experience during the transition of their loved one from home to care facilities

A new study shows that caregivers of dementia patients who must make the difficult decision to place their relatives into institutionalized care get no relief from depression and anxiety, and in fact suffer additional emotional trauma following their decision.

26 Aug 2004

Attention deficit/hyperactivity disorder high among Chernobyl children

In an extensive study of children exposed to varying levels of fallout from the 1986 Chernobyl Nuclear Power Plant accident, Israeli researchers have found that Attention Deficit/Hyperactivity Disorder (ADHD) scores are higher among those who were in-utero at the time of the accident -- regardless of their actual level of radiation exposure.

26 Aug 2004

FDA reinforces use of Sustiva in first-line HIV combination therapy

Bristol-Myers Squibb has announced that Sustiva® (efavirenz) has received approval from the U.S. Food and Drug Administration to include new long-term virologic and clinical data from BMS Study 006 in its prescribing information.

26 Aug 2004

High stress during pregnancy may increase likelihood of behavior problems in child

Children may be more likely to develop behavior problems like attention deficit disorder if their mothers report high levels of stress and anxiety during the earlier half of their pregnancy, researchers report in the journal Child Development.

25 Aug 2004

Body symmetry could be a tell tale sign of an aggressive person

Researchers may get some indication of how aggressively an angry person will react by measuring the size relationship between a person’s ears and other body parts, according to a new study.

23 Aug 2004

Significant link between depression and the development of coronary heart disease

A study of French power company employees has found a significant link between depression and the development of coronary heart disease (CHD). The research is published today in the International Journal of Epidemiology, edited in the Department of Social Medicine at Bristol University.

23 Aug 2004

Current information on the use of antidepressants in pediatric patients

The Food and Drug Administration has issued an update to provide health care providers and patients with the most current information on the use of antidepressants in pediatric patients.

21 Aug 2004

Newly discovered protein switch may be key to understanding sleep disorders, anxiety, and depression

University of California researchers have found that a newly discovered protein switch which they named neuropeptide S appears to work in the brain to enhance wakefulness and reduce anxiety in laboratory animals. According to Rainer Reinscheid and his colleagues, the protein could help in the understanding of sleep disorders, anxiety, and depression.

18 Aug 2004

Treatment of child depression most successful with Prozac and cognitive-behavior therapy combination

A new study by researchers at the UT Southwestern Medical Center at Dallas, have found that treatment of child depression was most successful when a combination of Prozac and cognitive-behavior therapy was applied.

18 Aug 2004

Prozac can now be found in Britain's drinking water and rivers

The British Environment Agency has reported that the anti-depression drug Prozac can now be found in Britain's drinking water. Prozac is being used at such an alarming rate in Britain that it is building up both in river systems and groundwater.

9 Aug 2004

Study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

The study will examine how much of an improvement in pain, stiffness, function and other symptoms is needed before patients consider the change important.

7 Aug 2004

Mefloquine, an anti-malarial drug plays a critical role in movement, vision and memory

Brown University researchers have discovered that mefloquine, an anti-malarial drug, blocks two gap junction proteins, or connexins, in low doses and with very few side effects in the brains of laboratory mice.

5 Aug 2004

Approval of an injectable filler to correct facial fat loss in people with HIV/AIDS

The Food and Drug Administration has approved an injectable filler to correct facial fat loss in people with human immunodeficiency virus (HIV) infection.

5 Aug 2004

New clinical study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

A new clinical study to determine how people with rheumatoid arthritis (RA) evaluate improvements in disease symptoms will be carried out by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the Department of Health and Human Services' National Institutes of Health.

5 Aug 2004

Overactive brain circuit brings on depression

A brain imaging study by the NIH's National Institute of Mental Health (NIMH) has found that an emotion-regulating brain circuit is overactive in people prone to depression – even when they are not depressed.

5 Aug 2004

17.6 million American adults (8.5 percent) meet standard diagnostic criteria for an alcohol use disorder

An estimated 17.6 million American adults (8.5 percent) meet standard diagnostic criteria for an alcohol use disorder and approximately 4.2 million (2 percent) meet criteria for a drug use disorder.

5 Aug 2004

Substance abuse and mood and anxiety disorders are some of the most common psychiatric disorders in the United States

Substance abuse and mood and anxiety disorders that arise independently of substance abuse and withdrawal are some of the most common psychiatric disorders in the United States, according to an article in the August issue of the Archives of General Psychiatry, one of the JAMA/Archives journals.

2 Aug 2004

Anxiety News and Research

Latest Anxiety News and Research

Mental distress increases risk of heart disease in diabetics

New study confirms benefits of rimonabant in weight loss

U.S. FDA study shows Canadian drugs to be more expensive

First study of the emotional turmoil caregivers experience during the transition of their loved one from home to care facilities

Attention deficit/hyperactivity disorder high among Chernobyl children

FDA reinforces use of Sustiva in first-line HIV combination therapy

High stress during pregnancy may increase likelihood of behavior problems in child

Body symmetry could be a tell tale sign of an aggressive person

Significant link between depression and the development of coronary heart disease

Current information on the use of antidepressants in pediatric patients

Newly discovered protein switch may be key to understanding sleep disorders, anxiety, and depression

Treatment of child depression most successful with Prozac and cognitive-behavior therapy combination

Prozac can now be found in Britain's drinking water and rivers

Study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

Mefloquine, an anti-malarial drug plays a critical role in movement, vision and memory

Approval of an injectable filler to correct facial fat loss in people with HIV/AIDS

New clinical study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

Overactive brain circuit brings on depression

17.6 million American adults (8.5 percent) meet standard diagnostic criteria for an alcohol use disorder

Substance abuse and mood and anxiety disorders are some of the most common psychiatric disorders in the United States

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Anxiety News and Research

Latest Anxiety News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in